Zentiva S.A. (BVB: SCD)

Market Cap	3.15B
Revenue (ttm)	1.09B
Net Income (ttm)	270.78M
Shares Out	697.02M
EPS (ttm)	0.39
PE Ratio	11.63
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,573
Open	4.420
Previous Close	4.420
Day's Range	4.420 - 4.520
52-Week Range	2.720 - 4.600
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 28, 2025

About Zentiva

Zentiva S.A. engages in the production and marketing of preparations and medicines for human use in Romania and internationally. The company develops pharmaceutical products in various therapeutic areas, such as cardiovascular diseases, anti-inflammatory and pain-relieving medications, urologists, blood diseases, gastrointestinal and metabolic disorders, central nervous system, infections, respiratory systems, and other. It also offers educational materials for healthcare professionals and patients. The company was formerly known as Sicomed S.A...

• Industry: Pharmaceutical Preparations
• Founded: 1962
• Employees: 1,035
• Stock Exchange: Bucharest Stock Exchange
• Ticker Symbol: SCD

Financial Performance

In 2023, Zentiva's revenue was 953.63 million, an increase of 25.54% compared to the previous year's 759.63 million. Earnings were 192.62 million, an increase of 93.65%.